AU2002314283A1 - Polypeptides reacting with hcv-infected patients' antibodies and uses - Google Patents

Polypeptides reacting with hcv-infected patients' antibodies and uses

Info

Publication number: AU2002314283A1
Authority: AU; Australia
Prior art keywords: hcv; antibodies; infected patients; polypeptides; reacting
Prior art date: 2001-05-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002314283A

Inventor

Colette Jolivet Reynaud

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Biomerieux SA

Original Assignee

Biomerieux SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-31

Filing date

2002-05-31

Publication date

2002-12-09

2002-05-31 Application filed by Biomerieux SA filed Critical Biomerieux SA

2002-12-09 Publication of AU2002314283A1 publication Critical patent/AU2002314283A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Communicable Diseases (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Physics & Mathematics (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Oncology (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Food Science & Technology (AREA)
Veterinary Medicine (AREA)
Analytical Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)

AU2002314283A 2001-05-31 2002-05-31 Polypeptides reacting with hcv-infected patients' antibodies and uses Abandoned AU2002314283A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0107184A FR2825363A1 (en)	2001-05-31	2001-05-31	POLYPEPTIDES REACTING WITH HCV-INFECTED PATIENT ANTIBODIES AND USES THEREOF
FR01/07184		2001-05-31
PCT/FR2002/001851 WO2002096929A2 (en)	2001-05-31	2002-05-31	Polypeptides reacting with hcv-infected patients' antibodies and uses

Publications (1)

Publication Number	Publication Date
AU2002314283A1 true AU2002314283A1 (en)	2002-12-09

Family

ID=8863850

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002314283A Abandoned AU2002314283A1 (en)	2001-05-31	2002-05-31	Polypeptides reacting with hcv-infected patients' antibodies and uses

Country Status (3)

Country	Link
AU (1)	AU2002314283A1 (en)
FR (1)	FR2825363A1 (en)
WO (1)	WO2002096929A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU698878B2 (en) *	1993-11-04	1998-11-12	Genimmune N.V.	Immunodominant human T-cell epitopes of hepatitis C virus
CA2354152A1 (en) *	1998-11-20	2000-06-02	Bio Merieux	Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications

2001
- 2001-05-31 FR FR0107184A patent/FR2825363A1/en active Pending
2002
- 2002-05-31 AU AU2002314283A patent/AU2002314283A1/en not_active Abandoned
- 2002-05-31 WO PCT/FR2002/001851 patent/WO2002096929A2/en not_active Ceased

Also Published As

Publication number	Publication date
WO2002096929A3 (en)	2003-12-24
FR2825363A1 (en)	2002-12-06
WO2002096929A2 (en)	2002-12-05

Similar Documents

Publication	Publication Date	Title
AU2002251913A1 (en)	2002-08-19	Hybrid antibodies and uses thereof
AU2002239991A1 (en)	2002-07-30	Electronic procurement ("e-procurement")
HUP0400284A3 (en)	2012-09-28	Recombinant tumor specific antibody and use thereof
AU2003253621A1 (en)	2003-12-31	Modified "s" antibodies
AU2002367859A1 (en)	2003-12-02	Polypeptide immobilization
GB9927332D0 (en)	2000-01-12	Novel antibody and uses thereof
EP1462455A4 (en)	2008-12-31	Novel peptides and medicinal uses thereof
AUPR546801A0 (en)	2001-06-28	Recombinant antibodies
AU2002312373A1 (en)	2002-12-23	Structural and cytoskeleton-associated proteins
AU3890200A (en)	2000-10-16	Novel porcine protein and uses thereof
AU2002314283A1 (en)	2002-12-09	Polypeptides reacting with hcv-infected patients' antibodies and uses
AU2399601A (en)	2001-07-03	Novel tachykinin-like polypeptides and use thereof
AU2001268531A1 (en)	2001-12-24	52871, a novel human g protein coupled receptor and uses thereof
AU2002320621A1 (en)	2003-03-03	Structural and cytoskeleton-associated proteins
AU2002360333A1 (en)	2003-05-12	Human angiomotin-like protein 1
AU2002344829A1 (en)	2003-01-08	Human ugrp (uteroglobin-related protein) 1 promoter and its use
AU2002357666A1 (en)	2003-05-06	69583 and 85924, novel human protein kinase family members and uses therefor
AU2002311203A1 (en)	2003-01-02	Novel polypeptide and use thereof
AUPR589701A0 (en)	2001-07-19	Novel peptide and use thereof
AU2003218703A1 (en)	2003-09-22	Specific ab1'-antibodies against tumour-associated antigen ca 125
AU2002313086A1 (en)	2002-12-09	Polypeptide which reacts with the antibodies of patients infected by hcv and uses thereof
AU2002354188B2 (en)	2008-11-27	Novel peptides and medicinal uses thereof
AU2002235434A1 (en)	2002-07-30	15569, a novel human g protein coupled receptor and uses therefor
AU2002252724A1 (en)	2002-11-05	The 76a11 polypeptide and uses thereof
AU2002230137A1 (en)	2002-08-19	Novel protein and use thereof

Legal Events

Date	Code	Title	Description
2004-03-11	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase